Clinical Trial Update: Megestrol Acetate for First-Line Treatment of Malnourished Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating megestrol acetate as first-line treatment for malnourished non-small cell lung cancer; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: Hunan Province Tumor Hospital | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: NOT_YET_RECRUITING